phenoxybenzamine has been researched along with Carcinoma, Hepatocellular in 1 studies
Phenoxybenzamine: An alpha-adrenergic antagonist with long duration of action. It has been used to treat hypertension and as a peripheral vasodilator.
Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| KIPLINGER, GF | 1 |
| KENSLER, CJ | 1 |
1 other study available for phenoxybenzamine and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Failure of phenoxybenzamine to prevent formation of hepatomas after chronic carbon tetrachloride administration.
Topics: Carbon Tetrachloride; Carbon Tetrachloride Poisoning; Carcinoma, Hepatocellular; Liver Neoplasms; Ph | 1963 |